Table 3.
Variable | Beta | 95% CI | p-Value |
---|---|---|---|
Age (years) | 0.00 | −0.02, 0.02 | 0.98 |
Sex: male vs. female | −0.07 | −0.40, 0.26 | 0.67 |
Baseline HbA1c (%) | −0.70 | −0.82, −0.58 | <0.001 |
Baseline BMI (kg/m2) | −0.04 | −0.08, −0.01 | 0.02 |
T2DM duration | 0.02 | 0.00, 0.04 | 0.02 |
Dose of oral semaglutide (mg) | 0.02 | −0.03, 0.06 | 0.49 |
Last follow-up (months) | −0.02 | −0.08, 0.03 | 0.44 |
Monotherapy vs. association | −0.30 | −1.1, 0.50 | 0.56 |
SWITCH vs. ADD-ON group | 0.25 | −0.14, 0.65 | 0.21 |
Insulin (yes vs. no) | 0.21 | −0.22, 0.63 | 0.33 |
SGLT2 (yes vs. no) | 0.12 | −0.23, 0.47 | 0.51 |
R2 = 0.625 |